Clinical trial
I.V Papavrine for Labor Induction in Term PROM: A Prospective Randomized Controlled Trial
NCT07517796 is registered in ClinicalTrials.gov with Western Galilee Hospital-Nahariya as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- I.V Papavrine for Labor Induction in Term PROM: A Prospective Randomized Controlled Trial
- Lead sponsor
- Western Galilee Hospital-Nahariya
- Phase
- Phase 4
- Overall status
- Recruiting
- Start date
- October 22, 2025
- Completion date
- October 22, 2027
- Enrollment
- 110 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
premature rupture of membranes